UBESLO

Serial Number 79405941
Registration 7830736
700

Registration Progress

Application Filed
Aug 30, 2024
Under Examination
Approved for Publication
Apr 23, 2025
Published for Opposition
Apr 29, 2025
Registered
Jun 17, 2025

Trademark Image

UBESLO

Basic Information

Serial Number
79405941
Registration Number
7830736
Filing Date
August 30, 2024
Registration Date
June 17, 2025
Published for Opposition
April 29, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 17, 2025
Registration
Registered
Classes
005

Rights Holder

NewAmsterdam Pharma B.V.

78
Address
Gooimeer 2 35
NL-1411 DC Naarden
NL

Ownership History

NewAmsterdam Pharma B.V.

Original Applicant
78
NL

NewAmsterdam Pharma B.V.

Owner at Publication
78
NL

NewAmsterdam Pharma B.V.

Original Registrant
78
NL

USPTO Deadlines

Next Deadline
1964 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20250617)
Due Date
June 17, 2031
Grace Period Ends
December 17, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

11 events
Date Code Type Description Documents
Jun 17, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 29, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 23, 2025 NPUB O NOTICE OF PUBLICATION Loading...
Apr 1, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 17, 2025 RFWR P NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW Loading...
Mar 13, 2025 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 12, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 5, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 8, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Oct 8, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 3, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for lowering cholesterol; pharmaceuticals, namely, lipid lowering agents; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, major adverse cardiac events, cholesterol-related diseases and disorders, dyslipidemia, lipid-related diseases and disorders, diabetes, age-related macular degeneration, neurodegenerative diseases and disorders, dementia, lewy body dementia, and alzheimer's disease

Classification

International Classes
005